-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BkzpbXlDqbaCsvFP9Iq4raTEOv2kZR3BgZ68qxU8eCN0bsSmgyj2Ic8fOAdmWGYC 6R5rn8KHx7uVmEY4LFUWIQ== 0000891554-96-000716.txt : 19961023 0000891554-96-000716.hdr.sgml : 19961023 ACCESSION NUMBER: 0000891554-96-000716 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19961022 SROS: NASD GROUP MEMBERS: MARX MOSES GROUP MEMBERS: MOMAR CORP. GROUP MEMBERS: UNITED EQUITIES CO. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34455 FILM NUMBER: 96646225 BUSINESS ADDRESS: STREET 1: 70 WOOD AVE S CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 9086328800 MAIL ADDRESS: STREET 1: 70 WOOD AVENUE SOUTH CITY: ISELIN STATE: NJ ZIP: 08830 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MARX MOSES CENTRAL INDEX KEY: 0000941992 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 BUSINESS PHONE: 2123492875 MAIL ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 SC 13D/A 1 SCHEDULE 13D AMEND NO.1 ------------------------------------------- OMB APPROVAL ------------------------------------------- OMB Number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per form................... 14.90 ------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* BIO-TECHNOLOGY GENERAL CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 090578-10-5 (CUSIP Number) Emanuel J. Adler, Esq. Tenzer Greenblatt LLP 405 Lexington Avenue New York, New York 10174 (212) 885-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notice and Communications) September 13, 1996 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Check the following box if a fee is being paid with the statement|_|. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 Pages CUSIP No. 090578-10-5 Page 2 of 7 Pages SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MOSES MARK - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 2,097,129 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH --- REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 2,097,129 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER --- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,097,129 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.7% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. Page 2 of 7 Pages CUSIP No. 090578-10-5 Page 3 of 7 Pages SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON UNITED EQUITIES (COMMODITIES) COMPANY - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 1,092,890 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH --- REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 1,092,890 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER --- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,092,890 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN, BD - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. Page 3 of 7 Pages CUSIP No. 090578-10-5 Page 4 of 7 Pages SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MOMAR CORP. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION MARYLAND - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 1,000,000 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH --- REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 1,000,000 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER --- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,000,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO, HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. Page 4 of 7 Pages This Amendment No. 1 amends and supplements the Schedule 13D, dated October 14, 1994 (the "Schedule 13D"), of Moses Marx, United Equities (Commodities) Company ("United Equities Commodities") and Momar Corp. ("Momar") (the "Reporting Persons"), with respect to the Common Stock, par value $.01 per share (the "Common Stock"), of Bio-Technology General Corp. (the "Company"). Except as modified hereby, there has been no change in the information previously reported in the Schedule 13D. Item 5. Interest in Securities of the Issuer. (a)-(b) According to the Company's Quarterly Report on Form 10-Q for the period ended June 30, 1996, there were outstanding 44,504,547 shares of Common Stock on August 9, 1996. Moses Marx Moses Marx beneficially owns 2,097,129 shares of Common Stock, comprising 4.7% of the issued and outstanding shares of the Common Stock, including (i) 4,239 shares (.0095%) owned directly by Mr. Marx; (ii) 1,092,890 shares (2.5%) owned of record by United Equities Commodities; and (iii) 1,000,000 shares (2.2%) owned of record by Momar, of which, with respect to the shares described in clauses (ii) and (iii), Mr. Marx may be deemed to be a beneficial owner by virtue of his being the only person in a position to determine the investment and voting decisions of United Equities Commodities and Momar with respect to such shares. Mr. Marx has the sole power to vote and dispose of all such shares. United Equities Commodities United Equities Commodities owns 1,092,890 shares of Common Stock, comprising 2.5% of the issued and outstanding shares of the Common Stock. Momar Momar owns 1,000,000 shares of Common Stock, comprising 2.2% of the issued and outstanding shares of the Common Stock. Page 5 of 7 Pages (c)(i) During the past 60 days, United Equities Commodities made the following sales of shares of Common Stock in open market transactions on the NASDAQ Small Cap Market: No. of Price Date Shares Sold Per share ---- ----------- --------- 08/21/96 80,000 $8.375 08/21/96 20,000 $8.50 08/21/96 20,000 $8.625 08/22/96 25,000 $8.750 08/22/96 25,000 $8.875 08/22/96 25,000 $9.00 08/22/96 25,000 $9.125 08/28/96 25,000 $9.625 (ii) On September 13, 1996, United Equities Commodities donated 200,000 shares of Common Stock to Terumah Foundation, a 501(c)(3) tax exempt organization. (iii) On September 30, 1996, Mr. Marx was issued 314 shares of Common Stock pursuant to the Company's Stock Compensation Plan. Other than as set forth above in Item 5(c), the Reporting Persons have not effected any transactions in the Common Stock in the last 60 days. (d) The Reporting Persons affirm that no person other than the Reporting Persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by them. (e) On September 13, 1996, the Reporting Persons ceased to be the owners of more than five percent (5%) of the shares of Common Stock of the Company. Page 6 of 7 Pages SIGNATURE --------- After reasonable inquiry, and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: October 21, 1996 /s/ Moses Marx --------------------------- MOSES MARX UNITED EQUITIES (COMMODITIES) COMPANY By: /s/ Moses Marx ------------------------- Moses Marx, General Partner MOMAR CORP. By: /s/ Moses Marx ------------------------- Moses Marx, President Page 7 of 7 Pages -----END PRIVACY-ENHANCED MESSAGE-----